Multiple myeloma (MM) presents as a significant public health challenge in Indonesia due to their high incidence and mortality rates. Due to its heterogeneous genetic landscape which plays a crucial role in determining patient prognosis, personalised treatment strategies need to be employed. This highlights the importance of the identification of genetic aberrancies in multiple myeloma patients…